NewsRoom Articles - Page 897 of 1416

MondayMar 18, 2019 3:30 pm

Lipocine Inc. (NASDAQ: LPCN) Attends 31st Annual ROTH Conference

Lipocine (NASDAQ: LPCN) is a specialty pharmaceutical company developing innovative pharmaceutical products using its proprietary drug delivery technologies. Lipocine's clinical development pipeline includes four development programs: TLANDO, to help restore normal testosterone levels in hypogonadal men; LPCN 1144, being developed as a treatment of non-alcoholic steatohepatitis; LPCN 1111, being developed as a next-generation oral testosterone product with potential for once-daily dosing and is currently in phase 2 testing; and LPCN 1107, potentially the first oral hydroxyprogesterone caproate product candidate indicated for the prevention of recurrent preterm birth and has been granted orphan drug designation by the FDA. For more information,…

MondayMar 18, 2019 3:30 pm

Limoneira Company (NASDAQ: LMNR) Attends 31st Annual ROTH Conference

Limoneira Company (NASDAQ: LMNR) is a 125-year-old international agribusiness headquartered in Santa Paula, California, has grown to become one of the premier integrated agribusinesses in the world. Limoneira is a dedicated sustainability company with 14,500 acres of rich agricultural lands, real estate properties, and water rights in California, Arizona and Chile. The company is a leading producer of lemons, avocados, oranges, specialty citrus and other crops that are enjoyed throughout the world. For more information, visit the company's website at www.limoneira.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network…

MondayMar 18, 2019 3:30 pm

Limbach Holdings Inc. (NASDAQ: LMB) Attends 31st Annual ROTH Conference

Limbach Holdings (NASDAQ: LMB) provides building infrastructure services with an expertise in the design, installation and maintenance of HVAC and mechanical, electrical, and plumbing systems for a diversified group of commercial and institutional building owners. Founded in 1901, Limbach employs more than1,850 employees in 15 offices throughout the United States. The company’s full life-cycle capabilities, from concept design and engineering through system commissioning and recurring 24/7 service and maintenance, position Limbach as a value-added and essential partner for building owners, construction managers, general contractors and energy service companies. For more information, visit the company's website at www.limbachinc.com. About NetworkNewsWire NetworkNewsWire…

MondayMar 18, 2019 3:00 pm

Aquantia Corp. (NYSE: AQ) Attends 31st Annual ROTH Conference

Aquantia (NYSE: AQ) designs, develops and markets advanced, high-speed communications ICs for Ethernet connectivity in the Data Center, Enterprise Infrastructure, Access and Automotive markets. Aquantia products are designed to cost-effectively deliver leading-edge data speeds for use in the latest generation of communications infrastructure to alleviate network bandwidth bottlenecks caused by the growth of global IP traffic. For more information, visit the company's website at www.aquantia.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective…

MondayMar 18, 2019 3:00 pm

Aptose Biosciences Inc. (NASDAQ: APTO) Attends 31st Annual ROTH Conference

Aptose Biosciences (NASDAQ: APTO) is a clinical-stage biotechnology company committed to developing personalized therapies addressing unmet medical needs in oncology, with an initial focus on hematology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. APTO-253, the only known clinical stage agent that directly targets the MYC oncogene and inhibits its expression, is in a phase 1b clinical trial for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) or high risk MDS. For more information, visit…

MondayMar 18, 2019 3:00 pm

Arcimoto Inc. (NASDAQ: FUV) Attends 31st Annual ROTH Conference

Arcimoto (NASDAQ: FUV) is devising new technologies and patterns of mobility that together raise the bar for environmental efficiency, footprint and affordability. Arcimoto is the maker of the Fun Utility Vehicle® (FUV) — an affordable, joyful, pure electric vehicle for everyday drivers and fleets. Available for pre-order today, Arcimoto has branded its FUV as one of the lightest, most affordable, and most appropriate electric vehicles suitable for the daily driver. For more information, visit the company's website at www.arcimoto.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire…

MondayMar 18, 2019 3:00 pm

Arch Therapeutics Inc. (ARTH) Attends 31st Annual ROTH Conference

Arch Therapeutics (OTCQB: ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's development stage product candidates include AC5™ Topical Gel, AC5™ Topical Hemostat1 and AC5™ Surgical Hemostat1. For more information, visit the company's website at www.archtherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to…

MondayMar 18, 2019 3:00 pm

AquaVenture (NYSE: WAAS) Attends 31st Annual ROTH Conference

AquaVenture (NYSE: WAAS) is a multinational provider of WAAS solutions that provide customers a reliable and cost-effective source of clean drinking and process water primarily under long-term contracts that minimize capital investment by the customer. AquaVenture is composed of two operating platforms: Quench, a leading provider of filtered water systems and related services with over 140,000 units installed at institutional and commercial customer locations across the U.S. and Canada; and Seven Seas Water, a multinational provider of desalination and wastewater treatment solutions, providing more than 8.5 billion gallons of potable, high purity industrial grade and ultra-pure water per year to…

MondayMar 18, 2019 3:00 pm

LightPath Technologies Inc. (NASDAQ: LPTH) Attends 31st Annual ROTH Conference

LightPath Technologies (NASDAQ: LPTH) is a global, vertically integrated provider of optics, photonics and infrared solutions for the industrial, commercial, defense, telecommunications and medical industries. LightPath designs, manufactures and distributes proprietary optical and infrared components including molded glass aspheric lenses and assemblies, infrared lenses and thermal imaging assemblies, fused fiber collimators, and proprietary Black Diamond ("BD6") chalcogenide-based glass lenses. LightPath also offers custom optical assemblies, including full engineering design support. LightPath's wholly owned subsidiary, ISP Optics Corporation, manufactures a full range of infrared products from high performance MWIR and LWIR lenses and lens assemblies. For more information, visit the company's…

MondayMar 18, 2019 3:00 pm

Ligand Pharmaceuticals Inc. (NASDAQ: LGND) Attends 31st Annual ROTH Conference

Ligand Pharmaceuticals (NASDAQ: LGND) is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand’s business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand’s business model is based on drug discovery, early-stage drug development, product reformulation and partnering. Ligand has established multiple alliances, licenses and other business relationships with the world's leading pharmaceutical companies including Novartis, Amgen, Merck, Pfizer, Celgene, Gilead, Janssen, Baxter International and Eli Lilly. For more information, visit…